← Leaderboards
Michael Elmo Coleman
Theratome Bio, Inc.
$538,130
Attributed
$538,130
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2018–19$500K$375K$250K$125K$0
'18
'19
Funding mix
By agency
NIH$538,130 · 2
By mechanism
R41$538,130 · 2
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Mesenchymal Stem Cells”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Avnesh Sinh Thakor · Stanford University$7,297,208
- Maribella Domenech-Garcia · Georgia Tech Research Corporation$5,835,925
- Steven L Stice · Georgia Tech Research Corporation$5,636,287
- Chang Hun Lee · Columbia University Health Sciences$5,341,536
- Nobuyuki Ishibashi · Children'S Research Institute$5,313,882
Research focus
Mesenchymal Stem CellsRepairedExperimental StudyMediatingRattusRegenerative MedicineConsultationsEngraftmentInjuryLegal PatentNext GenerationBaseAdipose TissueRecoveryBiological ProductsClinical TrialsDoseEffectivenessImmunoregulationIncidenceCellsIschemiaAffectSafety